Aspen Pharma Australia
Karine Fabre has a robust background in the biopharmaceutical industry, currently serving as a Senior Manager and Operational Manager at Aspen Pharma since May 2014. Fabre has held various roles including product specialist in the production of biological Active Pharmaceutical Ingredients (API) and has extensive experience in sterile injectable production from previous positions at GSK and Eli Lilly and Company. Education includes a Master's degree in Extractive Processes from Ecole Nationale Supérieure de Chimie Rennes and a DESS in Biology and Biotechnology from Université Saint Jérôme in Marseille. Fabre's expertise encompasses the construction and commissioning of recombinant enzyme production units, purification processes, and technical support in production, along with documentation and validation strategies.
This person is not in any teams
This person is not in any offices
Aspen Pharma Australia
1 followers
Aspen Australia is an entrepreneurial driven company which often works in partnership with other companies, including the multinationals. We are one of the largest pharmaceutical companies in Australia, and have one of the most comprehensive portfolios of medicines in the country, covering most disease states. The Aspen range includes Prescription pharmaceutical brands, Speciality pharmaceutical products and OTC healthcare. In addition, we have a thriving Export and Contract Manufacturing business. Our Branded Prescription Business has an emphasis on brand building and marketing a product on its merits. Our OTC Business puts us in the Top 5 OTC companies in the country.